NGVT Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$89.00median target· current $73.12 (+21.7%)4 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio102.97Forward 9.97
EPS (TTM)$0.71199.0% YoY
Profit margin4.7%BASIC MATERIALS
Market cap$2.51BMid cap
Valuation
- Forward P/E
- 9.97
- PEG ratio
- 2.41
- P/B
- 53.59
- P/S (TTM)
- 2.17
- EV/EBITDA
- 17.64
Profitability & growth
- ROE (TTM)
- 30.1%
- Operating margin
- 29.9%
- Revenue growth YoY
- -5.2%
- Dividend yield
- —
- Beta
- 1.17
Last earnings
Jul 29, 2026 · Estimate $1.31 · Reported $1.74
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Ingevity Corp
Company profileIngevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, Asia-Pacific, Europe, the Middle East, Africa, and South America. The company is headquartered in North Charleston, South Carolina.
Classification
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 4920 O'HEAR AVENUE, NORTH CHARLESTON, SC
- Fiscal year end
- December
- Latest quarter
- Jun 30, 2026
Market cap$2.51B
Shares outstanding$34.4M
52W high$79.29
52W low$45.66
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent